These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27354601)

  • 1. Early Experience with 70-150 μm Irinotecan Drug-eluting Beads (M1-DEBIRI) for the Treatment of Unresectable Hepatic Colorectal Metastases.
    Akinwande O; Scoggins C; Martin RC
    Anticancer Res; 2016 Jul; 36(7):3413-8. PubMed ID: 27354601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
    Bhutiani N; Akinwande O; Martin RC
    World J Surg; 2016 May; 40(5):1178-90. PubMed ID: 26711640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer.
    Narayanan G; Barbery K; Suthar R; Guerrero G; Arora G
    Anticancer Res; 2013 May; 33(5):2077-83. PubMed ID: 23645758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study.
    Martin RC; Joshi J; Robbins K; Tomalty D; Bosnjakovik P; Derner M; Padr R; Rocek M; Scupchenko A; Tatum C
    Ann Surg Oncol; 2011 Jan; 18(1):192-8. PubMed ID: 20740319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI(®)) for colorectal liver metastases does not predict tumour destruction or long-term outcome.
    Jones RP; Stättner S; Dunne DF; O'Grady E; Smethurst A; Terlizzo M; Malik HZ; Fenwick SW; Poston GJ
    Eur J Surg Oncol; 2013 Oct; 39(10):1122-8. PubMed ID: 23928482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.
    Martin RC; Scoggins CR; Schreeder M; Rilling WS; Laing CJ; Tatum CM; Kelly LR; Garcia-Monaco RD; Sharma VR; Crocenzi TS; Strasberg SM
    Cancer; 2015 Oct; 121(20):3649-58. PubMed ID: 26149602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review.
    Richardson AJ; Laurence JM; Lam VW
    J Vasc Interv Radiol; 2013 Aug; 24(8):1209-17. PubMed ID: 23885916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARAGON II - A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer.
    Jones RP; Malik HZ; Fenwick SW; Terlizzo M; O'Grady E; Stremitzer S; Gruenberger T; Rees M; Plant G; Figueras J; Albiol M; Adam R; Awad S; Poston GJ
    Eur J Surg Oncol; 2016 Dec; 42(12):1866-1872. PubMed ID: 27561844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant capecitabine with hepatic delivery of drug eluting beads in metastatic colorectal cancer.
    Akinwande O; Miller A; Hayes D; O'Hara R; Tomalty D; Martin RC
    Anticancer Res; 2014 Dec; 34(12):7239-45. PubMed ID: 25503155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial.
    Martin RC; Scoggins CR; Tomalty D; Schreeder M; Metzger T; Tatum C; Sharma V
    J Gastrointest Surg; 2012 Aug; 16(8):1531-8. PubMed ID: 22528576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: A systematic review.
    Akinwande O; Dendy M; Ludwig JM; Kim HS
    Surg Oncol; 2017 Sep; 26(3):268-275. PubMed ID: 28807246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial.
    Pernot S; Artru P; Mithieux F; Marsot J; Watkin E; Pellerin O; Lledo G; Chalabreysse P; Desramé J; Taieb J
    Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):e73-7. PubMed ID: 26141343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization.
    Scevola G; Loreni G; Rastelli M; Sposato S; Ramponi S; Miele V
    Med Oncol; 2017 Mar; 34(3):37. PubMed ID: 28160267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study.
    Venturini M; Sallemi C; Agostini G; Marra P; Cereda S; Reni M; Aldrighetti L; De Cobelli F; Del Maschio A
    Br J Radiol; 2016 Nov; 89(1067):20160247. PubMed ID: 27558984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study.
    Fiorentini G; Aliberti C; Tilli M; Mulazzani L; Graziano F; Giordani P; Mambrini A; Montagnani F; Alessandroni P; Catalano V; Coschiera P
    Anticancer Res; 2012 Apr; 32(4):1387-95. PubMed ID: 22493375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study.
    Iezzi R; Marsico VA; Guerra A; Cerchiaro E; Cassano A; Basso M; Devicienti E; Rodolfino E; Barone C; Bonomo L
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1523-31. PubMed ID: 25799948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report.
    Martin RC; Robbins K; Tomalty D; O'Hara R; Bosnjakovic P; Padr R; Rocek M; Slauf F; Scupchenko A; Tatum C
    World J Surg Oncol; 2009 Nov; 7():80. PubMed ID: 19886993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemoembolization for unresectable colorectal liver metastases with drug-eluting microspheres].
    Skupchenko AV; Lysenko AV; Korolev DG; Skobel'tsov DA; Rassudishkin AS
    Vestn Rentgenol Radiol; 2014; (6):33-8. PubMed ID: 25975131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial Chemoembolization of Liver Metastases from Uveal Melanoma Using Irinotecan-Loaded Beads: Treatment Response and Complications.
    Carling U; Dorenberg EJ; Haugvik SP; Eide NA; Berntzen DT; Edwin B; Dueland S; Røsok B
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1532-41. PubMed ID: 25832764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry.
    Martin RC; Howard J; Tomalty D; Robbins K; Padr R; Bosnjakovic PM; Tatum C
    Cardiovasc Intervent Radiol; 2010 Oct; 33(5):960-6. PubMed ID: 20661569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.